Joint Therapeutics Co., Ltd. was initiated in August 2022 and is a biotechnology company dedicated to innovative drug research and development, production, and ultimately promoting clinical applications. The company adopts a business model of "novel drugs as the core, with technology and product services as two wings". The core team members are the frontline personnels in the medical research and clinical service, including multiple overseas professionals and high-level national talents. We are committed to transforming cutting-edge scientific and technological innovation into innovative drugs and methods for clinical diagnosis and treatment, ultimately improving human health.